Article
Novel diagnostic, therapeutic, and prognostic biomarkers for nonalcoholic steatohepatitis-derived hepatocellular carcinoma: Capable to overcome the heterogeneity-specific barrier
2022-12-15
Abstract excerpt
Recent years have seen a rapid increase in the incidence of nonalcoholic steatohepatitis (NASH)-derived liver cancer, the heterogeneity-specific nature of biomarkers is significantly contributing to the high mortality rate worldwide. <h4>Objective: </h4> To screen new pathogenic genes associated with nonalcoholic steatohepatitis-derived hepatocellular carcinoma (NASH-related HCC) and related pathways, and break th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 029aa623-d9a6-5f3f-b866-5db3d0e344ec
- DOI
- 10.21203/rs.3.rs-2367007/v1